The Florida medical cannabis market, particularly low-THC products, has seen a dramatic decline in availability, which DocMJ attributes to a shift among dispensaries toward high-THC products in anticipation of Amendment 3's potential passage.
OG Article: here
View our Fair Use Policy: here
Low-THC sales by Trulieve and other major providers have decreased significantly in recent months, and patients reliant on high-CBD, low-THC products are struggling to access their preferred treatments.
Dispensaries are reportedly prioritizing higher-THC products to align with recreational use expectations, potentially leaving medical users with limited options.
Comments